...
首页> 外文期刊>Neurosurgery >Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas.
【24h】

Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas.

机译:腔内钇90胶体照射后复发性囊性颅咽管瘤的长期结果和晚期并发症。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Data were analyzed to assess the value of stereotactically applied intracystic colloidal yttrium-90 (YTx) for the treatment of recurrent cystic craniopharyngiomas during a 30-year period. METHODS: This article compares data from 73 YTx procedures in 60 patients between 1975 and 2006. The cumulative beta dose aimed at the inner surface of the cyst wall was 300 Gy. RESULTS: After YTx, the initial cyst volumes decreased an average of 79%. In 47, the reduction was more than 80%; in 27 of them, the cyst disappeared completely within 1 year. The mean survival after YTx was 9.4 years (range, 0.7-30 yr). Actuarial survival rates at 5, 10, 15, 20, 25, and 30 years were 81, 61, 45, 18, 2, and 0%, respectively. Late complications of YTx were related to the anatomic localization of the cyst, either presellar and retrosellar, e.g., a presellar (prechiasmatic/suprasellar) localization caused neuro-ophthalmological complications in 5.8% and internal carotid artery injury in 1.6%. The treatment of retrosellar (retrochiasmatic, suprasellar) tumors occasionally induced hypothalamic and/or pontomesencephalothalamic damage obviously by untoward radiation to the so-called perforating arteries. This occurred in 3.2% of these latter patients. CONCLUSION: Despite sporadic complications, intracavitary YTx irradiation is a valuable treatment alternative for craniopharyngioma cysts, sometimes as part of a multimodality management in these tumors, especially in precarious surgical cases.
机译:目的:分析数据以评估立体定向应用囊内胶体钇90(YTx)在30年内治疗复发性囊性颅咽管瘤的价值。方法:本文比较了1975年至2006年期间60例患者的73例YTx手术的数据。针对囊肿壁内表面的累积beta剂量为300 Gy。结果:YTx后,最初的囊肿体积平均减少了79%。 47个国家/地区减少了80%以上;其中27例在一年内囊肿完全消失。 YTx治疗后的平均生存期为9.4年(范围0.7-30岁)。 5、10、15、20、25和30年的精算生存率分别为81%,61%,45%,18%,2%和0%。 YTx的晚期并发症与囊肿的解剖定位有关,无论是鞍前还是鞍后,例如,鞍前(前chi突/鞍上)定位引起的神经眼科并发症为5.8%,颈内动脉损伤为1.6%。后巩膜(逆行气管,上丘脑)肿瘤的治疗有时会通过对所谓的穿通动脉的不良辐射而明显引起下丘脑和/或桥脑脑丘脑损伤。在这些后者患者中有3.2%发生了这种情况。结论:尽管有零星的并发症,但腔内YTx照射是颅咽管瘤囊肿的一种有价值的治疗选择,有时作为这些肿瘤多模式治疗的一部分,尤其是在不稳定的手术病例中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号